These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7736951)

  • 21. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence.
    Chrostek L; Cylwik B; Szmitkowski M; Korcz W
    Clin Chim Acta; 2006 Feb; 364(1-2):167-71. PubMed ID: 16087169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory diagnosis of ethyl alcohol dependence syndrome].
    Markowski T; Arciuch LP; Zwierz K; Bakush AA
    Postepy Hig Med Dosw; 2001; 55(1):113-20. PubMed ID: 11355526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis.
    Perret R; Froehlich F; Lavanchy D; Henry H; Bachman C; Pécoud A; Bianchi L; Gonvers JJ
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1337-42. PubMed ID: 9347098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [biological markers for alcohol abuse].
    van de Wiel A; Wielders JP
    Ned Tijdschr Geneeskd; 2009 Apr; 153(17):818-23. PubMed ID: 19469215
    [No Abstract]   [Full Text] [Related]  

  • 25. [CDT (desialylated transferrin)--a new biochemical marker of alcohol abuse].
    Chrostek L; Szmitkowski M
    Psychiatr Pol; 1999; 33(2):189-201. PubMed ID: 10786224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Considerations on the use of carbohydrate-deficient transferrin in officially recognized medial psychological examination centers].
    Müller-Wickop J; Löhr-Schwaab S; Jansen J
    Blutalkohol; 1995 Mar; 32(2):65-73. PubMed ID: 7748524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting alcoholic relapse posttransplant.
    Jowsey SG
    Liver Transpl; 2000 Nov; 6(6):812-4. PubMed ID: 11084075
    [No Abstract]   [Full Text] [Related]  

  • 28. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism.
    Allen JP; Sillamaukee P; Anton R
    Alcohol Clin Exp Res; 1999 Jan; 23(1):115-20. PubMed ID: 10029211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoelectric focusing (IEF) and immunofixation for determination of disialotransferrin.
    Dumon MF; Nau A; Hervouet M; Paccalin J; Clerc M
    Clin Biochem; 1996 Dec; 29(6):549-53. PubMed ID: 8939402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic tests of alcohol consumption].
    Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2002 Aug; 13(74):154-7. PubMed ID: 12420351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean erythrocyte volume as laboratory markers of chronic alcohol abuse].
    Dastych M; Bednarík J; Pokora J; Friedecký B; Novotná H; Moravcová E; Vávrová J
    Vnitr Lek; 2003 Feb; 49(2):115-20. PubMed ID: 12728578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPLC and mass spectrometric characterization of a candidate reference material for the alcohol biomarker carbohydrate-deficient transferrin (CDT).
    Oberrauch W; Bergman AC; Helander A
    Clin Chim Acta; 2008 Sep; 395(1-2):142-5. PubMed ID: 18590715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence.
    Bean P; Harasymiw J; Peterson CM; Javors M
    Alcohol Clin Exp Res; 2001 Feb; 25(2):309-16. PubMed ID: 11236848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Validity and use of biological marker tests for alcoholism].
    Aubin HJ
    Rev Prat; 2006 May; 56(10):1065. PubMed ID: 16874952
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced clinical utility of gamma-CDT in a general population.
    Sillanaukee P; Massot N; Jousilahti P; Vartiainen E; Poikolainen K; Olsson U; Alho H
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1202-6. PubMed ID: 10968658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New applications of contemporary biomarkers of alcohol consumption.
    Bean P; De Bruin T; Harasymiw J; Hallinan P
    Am Clin Lab; 2002 Mar; 21(2):19-21. PubMed ID: 11993250
    [No Abstract]   [Full Text] [Related]  

  • 38. Detecting alcohol abuse: the value of carbohydrate deficient transferrin.
    Stout RL
    J Insur Med; 1998; 30(2):123-4. PubMed ID: 10339297
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbohydrate-deficient transferrin, gamma-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women.
    Allen JP; Litten RZ; Fertig JB; Sillanaukee P
    Alcohol Clin Exp Res; 2000 Apr; 24(4):492-6. PubMed ID: 10798585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients.
    Rinck D; Frieling H; Freitag A; Hillemacher T; Bayerlein K; Kornhuber J; Bleich S
    Drug Alcohol Depend; 2007 Jun; 89(1):60-5. PubMed ID: 17234365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.